Navigation Links
WX Crowned 'Chemistry CRO of the Year' by Pfizer
Date:4/4/2008

SHANGHAI, China, April 4, 2008 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it was awarded the 2007 Chemistry CRO of the Year Award by the Pfizer Chemistry Sourcing Center of Emphasis (CoE).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Richard Connell, Head of the Chemistry Sourcing CoE, presented the award plaque to Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, at a recent Steering Committee meeting held in Groton, Connecticut. WuXi PharmaTech has enjoyed a close and cooperative relationship with Pfizer for many years, with collaborations ranging from synthetic chemistry, parallel medicinal chemistry (PMC), and ADME to bioanalytical services. The award recognizes in particular the outstanding collaboration of the WuXi and Pfizer teams in an effort to shorten the cycle times between requests for and delivery of parallel medicinal chemistry.

Pfizer's Centers of Emphasis state their mission as "Delivering Value Through Partnership." The success of their partnership with WuXi was certainly reflected in this year's presentation of their Top Chemistry CRO Award.

As the largest pharmaceutical, biotechnology and medical device contract research organization, WuXi collaborates with Pfizer in a number of drug discovery and development areas. Dr. Gonghua Pan of Pfizer, a key member of the collaboration, commented on the impact, "With WuXi's help, we reduced the average time from submitting the request to shipping of the finished product from 65 days in 2006 to 43 days in 2007, and at no increase in cost. This improvement reflects their own corporate commitment to continuous improvement - a commitment embedded in their slogan, 'we are determined to serve you better(R).'"

"We are very honored to receive this recognition from Pfizer, one of our largest customers for many years, and we really appreciate the trust and support Pfizer has given us. In order to better serve our customers we are building a global service and resource platform that has both small molecule and biologics capabilities covering early stage discovery to commercial manufacturing. By continuously improving our services and operation excellence, we will live up to our service creed 'We are determined to serve you better(R),'" commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.

About WuXi PharmaTech

WuXi PharmaTech, headquartered in Shanghai, China, is a leading global pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the U.S. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to pharmaceutical, biotechnology and medical device companies. Our services are designed to assist our global customers in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions. For more information, please visit: http://www.wuxipharmatech.com.

CONTACT:

Sherry Shao

WuXi PharmaTech Inc.

+86 (21) 5046-4002


'/>"/>
SOURCE WuXi PharmaTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative
2. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
3. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
4. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
5. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
6. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
7. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
8. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
11. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):